SHIN NIPPON BIOMEDICAL LABORATORIES financial statements, including revenue, expenses, profit, and loss

The total revenue of 2395 for the last quarter is 6.96 B JPY, and it's 25.40% higher compared to the previous quarter. The net income of Q2 24 is 1.21 B JPY.